Latest News and Press Releases
Want to stay updated on the latest news?
-
Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) - Angelini Pharma will invest US$35 million and be the sole investor in this innovative fund - ALBF will invest...
-
Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund (ALBF) - Angelini Pharma will invest US$35 million and be the sole investor in this innovative fund - ALBF will invest...
-
Toronto, ON, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Notch Therapeutics, a company in the emerging field of gene-modified T cell therapy, has been created to commercialize a revolutionary technology that...